90 related articles for article (PubMed ID: 22566228)
1. Neutralization of heparin activity.
Pai M; Crowther MA
Handb Exp Pharmacol; 2012; (207):265-77. PubMed ID: 22566228
[TBL] [Abstract][Full Text] [Related]
2. Recombinant platelet factor 4 reversal of heparin in human cardiopulmonary bypass blood.
Williams RD; D'Ambra MN; Maione TE; Lynch KE; Keene DF
J Thorac Cardiovasc Surg; 1994 Nov; 108(5):975-83. PubMed ID: 7967683
[TBL] [Abstract][Full Text] [Related]
3. Reversal of heparin anticoagulation by recombinant platelet factor 4 and protamine sulfate in baboons during cardiopulmonary bypass.
Bernabei A; Gikakis N; Maione TE; Kowalska MA; Yan Z; Niewiarowski S; Edmunds LH
J Thorac Cardiovasc Surg; 1995 Apr; 109(4):765-71. PubMed ID: 7715225
[TBL] [Abstract][Full Text] [Related]
4. Antagonism of SR 90107A/Org 31540-induced bleeding by protamine sulfate in rats and mice.
Bernat A; Hoffmann P; Herbert JM
Thromb Haemost; 1996 Nov; 76(5):715-9. PubMed ID: 8950779
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of recombinant platelet factor 4 and protamine sulfate for heparin neutralization: clotting and clearance studies in rat.
Korutla LN; Stewart GJ; Lasz EC; Maione TE; Niewiarowski S
Thromb Haemost; 1994 May; 71(5):609-14. PubMed ID: 8091389
[TBL] [Abstract][Full Text] [Related]
6. Randomized trial of recombinant platelet factor 4 versus protamine for the reversal of heparin anticoagulation in humans.
Dehmer GJ; Lange RA; Tate DA; Pirwitz M; Daniel W; Fisher M; Bonnem EM
Circulation; 1996 Nov; 94(9 Suppl):II347-52. PubMed ID: 8901773
[TBL] [Abstract][Full Text] [Related]
7. Interrelationship of protamine and platelet factor 4 in the neutralization of heparin.
Shanberge JN; Quattrociocchi-Longe TM; Martens MH
Thromb Res; 1987 Apr; 46(1):89-100. PubMed ID: 3590116
[TBL] [Abstract][Full Text] [Related]
8. Some objective considerations for the neutralization of the anticoagulant actions of recombinant hirudin.
Fareed J; Walenga JM; Pifarre R; Hoppensteadt D; Koza M
Haemostasis; 1991; 21 Suppl 1():64-72. PubMed ID: 1894198
[TBL] [Abstract][Full Text] [Related]
9. Strategies for improving the functionality of an affinity bioreactor.
Wang T; Yang Z; Emregul E; David A; Balthasar JP; Liang J; Yang VC
Int J Pharm; 2005 Dec; 306(1-2):132-41. PubMed ID: 16246511
[TBL] [Abstract][Full Text] [Related]
10. Platelet factor four and protamine sulfate neutralization of heparin fractionated according to anionic charge density.
Poon MC; Hurst RE; Rives MS
Thromb Haemost; 1982 Apr; 47(2):162-5. PubMed ID: 7101237
[TBL] [Abstract][Full Text] [Related]
11. Can extra protamine eliminate heparin rebound following cardiopulmonary bypass surgery?
Teoh KH; Young E; Blackall MH; Roberts RS; Hirsh J
J Thorac Cardiovasc Surg; 2004 Aug; 128(2):211-9. PubMed ID: 15282457
[TBL] [Abstract][Full Text] [Related]
12. Heparin therapy during extracorporeal circulation. II. The use of a dose-response curve to individualize heparin and protamine dosage.
Bull BS; Huse WM; Brauer FS; Korpman RA
J Thorac Cardiovasc Surg; 1975 May; 69(5):685-9. PubMed ID: 1127967
[TBL] [Abstract][Full Text] [Related]
13. Neutralization of a low molecular weight heparin (LHN-1) and conventional heparin by protamine sulfate in rats.
Diness V; Ostergaard PB
Thromb Haemost; 1986 Dec; 56(3):318-22. PubMed ID: 3563964
[TBL] [Abstract][Full Text] [Related]
14. Mechanism of low-molecular-weight heparin reversal by platelet factor 4.
Fiore MM; Mackie IM
Thromb Res; 2009 May; 124(1):149-55. PubMed ID: 19195682
[TBL] [Abstract][Full Text] [Related]
15. Reversing anticoagulants both old and new.
Warkentin TE; Crowther MA
Can J Anaesth; 2002; 49(6):S11-25. PubMed ID: 12557411
[TBL] [Abstract][Full Text] [Related]
16. Heparin-induced thrombocytopenia and cardiopulmonary bypass: anticoagulation with unfractionated heparin and the GPIIb/IIIa inhibitor tirofiban and successful use of rFVIIa for post-protamine bleeding due to persistent platelet blockade.
Durand M; Lecompte T; Hacquard M; Carteaux JP
Eur J Cardiothorac Surg; 2008 Sep; 34(3):687-9. PubMed ID: 18579401
[TBL] [Abstract][Full Text] [Related]
17. Complications of heparin therapy.
Gervin AS
Surg Gynecol Obstet; 1975 May; 140(5):789-96. PubMed ID: 1170648
[TBL] [Abstract][Full Text] [Related]
18. [Heparin in surgery and artificial circulation: pro and contra. Is there an alternative?].
Roĭtman EV; Dement'eva II; Meshcheriakov AV
Anesteziol Reanimatol; 1997; (6):65-9. PubMed ID: 9511253
[No Abstract] [Full Text] [Related]
19. A comparison of thromboelastography with heparinase or protamine sulfate added in vitro during heparinized cardiopulmonary bypass.
Spiess BD; Wall MH; Gillies BS; Fitch JC; Soltow LO; Chandler WL
Thromb Haemost; 1997 Aug; 78(2):820-6. PubMed ID: 9268178
[TBL] [Abstract][Full Text] [Related]
20. Detection of protamine and heparin after termination of cardiopulmonary bypass by thrombelastometry (ROTEM): results of a pilot study.
Mittermayr M; Velik-Salchner C; Stalzer B; Margreiter J; Klingler A; Streif W; Fries D; Innerhofer P
Anesth Analg; 2009 Mar; 108(3):743-50. PubMed ID: 19224778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
